ICRA Limited has upgraded the credit ratings for KIMS Healthcare Management Limited (KHML) to [ICRA]AA(Stable) for long-term instruments and reaffirmed [ICRA]A1+ for short-term instruments. The rating agency has also assigned a stable outlook and removed the ratings from ‘Watch with Developing Implications’. The upgrade reflects KHML’s improved credit profile, driven by its parent Aster DM Quality Care Limited’s stronger financial position and operational synergies.
KIMS Healthcare Management Limited Sees Credit Rating Upgrade
ICRA Limited has announced an upgrade in the credit ratings for KIMS Healthcare Management Limited (KHML), a material subsidiary of Aster DM Quality Care Limited. The long-term rating for fund-based instruments has been revised to [ICRA]AA(Stable), moving up from [ICRA]AA-. Similarly, the short-term rating for non-fund based instruments has been reaffirmed at [ICRA]A1+. Both have been removed from ‘Rating Watch with Developing Implications’ with a stable outlook assigned.
Key Rating Actions
The upgrade reflects ICRA’s assessment of KHML’s enhanced credit profile, significantly influenced by the strengthened financial risk profile of its parent, Aster DM Quality Care Limited (ADMQCL). The rating agency notes the completion of the merger between Quality Care India Limited and Aster DM Healthcare Limited, resulting in a larger and more diversified entity in ADMQCL. KHML is considered strategically important to ADMQCL due to its strong brand presence in Kerala and Tamil Nadu, with a combined bed capacity of 1,560 as of March 31, 2026.
Specifically, the long-term ratings for Fund-based – Cash Credit (₹19.00 crore) and Term Loan (₹75.00 crore) have been upgraded to [ICRA]AA(Stable). The short-term rating for Non-fund Based – Others (₹12.00 crore) has been reaffirmed at [ICRA]A1+. The unallocated long-term/short-term facility of ₹104.00 crore also sees an upgrade in its long-term component to [ICRA]AA(Stable), with the short-term component reaffirmed at [ICRA]A1+.
Rationale for Upgrade
The upgrade is supported by KHML’s healthy financial performance, characterized by a strong CAGR of approximately 25% over the five-year period ending FY2026. Revenue growth has been robust, driven by healthy patient volumes and improved average revenue per occupied bed day (ARPOB). The operating margin has also seen a significant improvement. Furthermore, KHML is expected to benefit from operational synergies with its parent, ADMQCL.
ICRA highlights KHML’s strong brand reputation in Trivandrum, a diversified specialty mix, and a healthy financial profile, including comfortable debt metrics. The company’s liquidity position is also strong, supported by healthy cash and bank balances and unutilised working capital limits.
Key Rating Drivers
- Credit Strengths: Strong brand reputation in Trivandrum, diversified specialty mix, healthy financial profile, and implicit support from the parent, Aster DM Quality Care Limited.
- Credit Challenges: High dependence on the Trivandrum hospital, regulatory risks, competition, and the challenge of doctor retention.
Despite the concentration risk associated with the Trivandrum facility, ICRA expects the gradual scaling up of newer facilities to support revenue diversification over the medium term.
Source: BSE
